|
| search over 1,000 Venture Capital related sites |
| 1. | http://www.lillyventures.com/html/contact.htm (100%): *** Replace left1.gif through left7.gif with the appropriate left-side image components Submitting a business plan to Lilly Ventures is an easy process. We prefer to receive business plans via e-mail and invite you to submit your non-confidential company information electronically. If you wish to s... |
| 2. | http://www.lillyventures.com/html/eLillyIC.htm (73%): *** Replace left1.gif through left7.gif with the appropriate left-side image components Investment Committee | Investment Professionals | Our Portfolio | Focus Alpheus Bingham, Ph.D. Dr. Bingham was named Vice President, e.Lilly in September 2002. He received a B.S. in chemistry from Brigham Young ... |
| 3. | e.Lilly > about e.Lilly > executive biographies (72%): When we created e.Lilly, we assembled a management team made up of some of Lilly’s most experienced creative thinkers. Current members of the e.Lilly team are: Alph Bingham, Vice President, e-Research and Development A native of California, Dr. Bingham joined Lilly in 1978. He received a Bach... |
| 4. | e.Lilly > about e.Lilly > faq (63%): leadership | faqs Below represents the most frequently asked questions of e.Lilly. By clicking on a question (or scrolling down the list), you will see both the questions and our corresponding answer. General Is e.Lilly a new company? What is the essence of e.Lilly? How is e.Lilly different from Lil... |
| 5. | Lilly: Careers (61%): investment models | venture services | submit your venture proposal e.Lilly leverages Eli Lilly and Company's pharmaceutical expertise and financing capabilities to turn innovative startups into successful companies. e.Lilly not only explores new technology opportunities via operating agreements wit... |
| 6. | http://www.lillyventures.com (57%): Lilly Ventures is the venture capital arm of Eli Lilly and Company , a leading innovation-driven pharmaceutical company. Our primary goal is to facilitate the success of companies in our areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently ... |
| 7. | http://www.lillyventures.com/index.htm (57%): Lilly Ventures is the venture capital arm of Eli Lilly and Company , a leading innovation-driven pharmaceutical company. Our primary goal is to facilitate the success of companies in our areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently ... |
| 8. | e.Lilly > about e.Lilly (47%): leadership | faqs e.Lilly is an Eli Lilly and Company initiative focused on engaging our potential creative partners in a dialogue to explore new ventures and new ways of working. We’re specifically focused on ideas and strategies that will enable Lilly to grow, be innovative, and better serve ... |
| 9. | welcome to e.Lilly (44%): ...the place where creative partners of Eli Lilly and Company can explore business strategies and career opportunities, offer new ideas, and help us continue our long tradition of innovation and excellence in the global pharmaceutical industry. We’re looking for suggestions for reshaping our co... |
| 10. | welcome to e.Lilly (44%): ...the place where creative partners of Eli Lilly and Company can explore business strategies and career opportunities, offer new ideas, and help us continue our long tradition of innovation and excellence in the global pharmaceutical industry. We’re looking for suggestions for reshaping our co... |
| 11. | A.M. Pappas And Associates: About Us: Our Team: C. Robert Hallford (44%): About Us Our Team Our Network Where to Find Us Investment Funds Pappas Ventures Portfolio Companies Investment Criteria News Home C. Robert Hallford Associate Rob joined AMP&A in 2005 after completing his MBA at Duke University's Fuqua School of Business. Prior to business school, Rob worked for eig... |
| 12. | welcome to e.Lilly (43%): ...the place where creative partners of Eli Lilly and Company can explore business strategies and career opportunities, offer new ideas, and help us continue our long tradition of innovation and excellence in the global pharmaceutical industry. We’re looking for suggestions for reshaping our co... |
| 13. | http://www.lillyventures.com/html/ELVfocus.htm (40%): *** Replace left1.gif through left7.gif with the appropriate left-side image components Investment Committee | Investment Professionals | Our Portfolio | Focus e.Lilly Venture Fund targets investments in early to expansion stage start-up companies with innovative network technology that can transfo... |
| 14. | http://www.lillyventures.com/html/MTVportfolio.htm (40%): *** Replace left1.gif through left7.gif with the appropriate left-side image components e.Lilly Venture Fund Portfolio | Lilly BioVenture Fund Portfolio | Lilly MedTech Venture Fund Portfolio Remon Medical Technologies Inc , Waltham, MA and Caesaria, Israel Remon Medical Technologies develops and c... |
| 15. | H.I.G. VENTURES: Our Team (39%): Aaron Davidson is a Managing Director of H.I.G. Ventures and focuses on investment opportunities in the life sciences sector. Prior to joining H.I.G., he was a Vice President with Ventures West with a focus on venture investing in life sciences companies. Aaron began his career with Eli Lilly Compa... |
| 16. | H.I.G. VENTURES: Our Team (39%): Aaron Davidson is a Managing Director of H.I.G. Ventures and focuses on investment opportunities in the life sciences sector. Prior to joining H.I.G., he was a Vice President with Ventures West with a focus on venture investing in life sciences companies. Aaron began his career with Eli Lilly Compa... |
| 17. | 5AM Ventures - Company Profile (39%): AMBRX ASSEMBLES WORLD CLASS TEAM AND RAISES $12.5 MILLION TO APPLY BREAKTHROUGH TECHNOLOGY TO PROTEIN THERAPEUTICS SAN DIEGO, California -- September 22, 2003 - Ambrx, Inc., a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics, announced that Richard D. DiMarchi, P... |
| 18. | http://www.lillyventures.com/html/InvestmentProfessionals.htm (38%): *** Replace left1.gif through left7.gif with the appropriate left-side image components Ron Laufer, M.D. - Principal Dr. Laufer led the investments in Remon Medical Technologies, Cellular Genomics, and Nanostream; companies which he serves as a board observer. He has nine years of experience in cli... |
| 19. | http://www.lillyventures.com/html/ELVInvestmentProfessionals.htm (38%): *** Replace left1.gif through left7.gif with the appropriate left-side image components Investment Committee | Investment Professionals | Our Portfolio | Focus Ron Laufer, M.D. - Principal Dr. Laufer led the investments in Remon Medical Technologies, Cellular Genomics, and Nanostream; companies whi... |
| 20. | http://www.lillyventures.com/html/LBVInvestmentProfessionals.htm (38%): *** Replace left1.gif through left7.gif with the appropriate left-side image components Advisory Board | Investment Professionals | Our Portfolio | Focus Ron Laufer, M.D. - Principal Dr. Laufer led the investments in Remon Medical Technologies, Cellular Genomics, and Nanostream; companies which he ... |
|
VC Directory:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
others
*Not every vc in the directory is indexed by searchvc.com. |
